Low-dose oral pimobendan emancipates patients with severe ischemic pump failure from intravenous catecholamine infusion for cardiogenic shock

Int J Cardiol. 2016 Jan 1:202:829-30. doi: 10.1016/j.ijcard.2015.10.041. Epub 2015 Oct 9.
No abstract available

Keywords: Cardiogenic shock; Ischemic heart disease; Low-dose pimobendan.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Aged, 80 and over
  • Cardiotonic Agents / administration & dosage
  • Catecholamines / administration & dosage
  • Catecholamines / adverse effects*
  • Dose-Response Relationship, Drug
  • Electrocardiography
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Myocardial Infarction / complications
  • Myocardial Infarction / drug therapy*
  • Pyridazines / administration & dosage*
  • Severity of Illness Index
  • Shock, Cardiogenic / chemically induced
  • Shock, Cardiogenic / drug therapy*

Substances

  • Cardiotonic Agents
  • Catecholamines
  • Pyridazines
  • pimobendan